Salve Medica Sp. z o.o. S.K.

Lodz 12 trials 5 recruiting

12 Registered trials

5 Currently recruiting

Organisation

Salve Medica Sp. z o.o. S.K.

Location

Lodz, Poland

Identifier

ORG-100042078

Address

Ul. Szparagowa 10, 91-211, Poland

Departments

Alergology
Clinical Trial
Gynecology
N/A
Oncology
Ośrodek Badań Klinicznych Salve Medica
Poradnia POZ
Salve Medica -Przychodnia

Clinical trials at this site (12)

Search interface

A prospective, controlled, randomized, double blind, 2-arms, parallel-group, multicentre, phase 3 study to investigate effectiveness of Acti… Pending

2024-516284-90-00 rhinosinusitis not requiring antibiotic therapy 5
An Open-label, Randomized, Phase 3 Study to Evaluate Patritumab Deruxtecan Monotherapy versus Treatment of Physician’s Choice in Hormone Rec… Recruiting

2025-520582-51-00 Hormone receptor positive breast cancer 5 2025-10-17
A clinical study of sac-TMT in people with breast cancer (MK-2870-032) Recruiting

2024-520190-12-00 Breast Cancer: triple negative breast cancer (TNBC) and 5 2025-11-10
Cytisine for nicotine-containing electronic cigarette and tobacco cigarette cessation: a randomized placebo-controlled trial Recruiting

2023-504708-27-00 electronic cigarette cessation 5 2024-11-02
Allopurinol as a preventive drug in patients with high and very high cardiovascular risk, taking into account the presence of the long-COVID… Recruiting

2024-517610-15-00 hyperuricemia, hypertension, ischemic stroke, intracere 5 2024-03-28
A study of tucatinib with trastuzumab and mFOLFOX6 versus standard of care treatment in first-line HER2+ metastatic colorectal cancer Recruiting

2024-514180-25-00 unresectable or metastatic HER2+ colorectal cancer 5 2022-11-21
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women with Breast Cancer Who Are Having Hormone Therapy Ended

2024-510719-31-00 Moderate to Severe Vasomotor Symptoms (VMS) 5 2025-01-24
Phase Ib/III Study of Capivasertib + CDK4/6 Inhibitors + Fulvestrant as Treatment for Advanced/Metastatic HR+/HER2-Breast Cancer (CAPItello-… Ended

2023-504997-39-00 Hormone Receptor-Positive and Human Epidermal Growth Fa 5 2021-06-14
Impact of trimetazidine on endothelial function and biomarkers correlating with the prognosis of heart failure with preserved ejection fract… Ended

2023-506138-65-00 Heart failure with preserved ejection fraction 6 2025-02-20
A prospective, randomized, double-blind placebo-controlled multicentre study with mannan-conjugated birch pollen allergoids administered sub… Ended

2023-508013-16-00 Birch pollen induced allergic rhinitis or rhinoconjunct 5 2024-02-26
A double-blind, randomised, dose-finding trial to assess the efficacy, safety and pharmacokinetics of a single dose of albaconazole versus f… Ended

2023-504727-32-00 Acute vulvovaginal candidiasis 4 2023-09-18
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease … Ended

2023-506926-35-00 Atherosclerotic cardiovascular disease, chronic kidney 5 2021-09-24